Mathieu Roche discusses the role of identity in digital advertising performance, emphasizing transparent data collection and ...

Shares of Roche drew increased retail attention Monday after the Swiss drugmaker said it would move its investigational ...

Shares of MAIA Biotechnology, Inc. (MAIA) soared 12% on Wednesday morning after the company said that it entered into a ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...

Roche and AbbVie have come up short again in their effort to gain an additional indication for their blockbuster blood cancer ...

George A. Roche, the former chairman and CEO of T. Rowe Price, oversaw dramatic growth there, and his philanthropy has ...

Amazon has slashed the price of La Roche Posay's highly rated dark spot serum by nearly 50% and shoppers have been praising ...